US 2025/0049775 A1 · USE OF AMINOPYRAZOLE COMPOUNDS

Abstract

The current invention provides the use compounds of Formula (I) which are JAK inhibitors, and as such for the treatment of JAK-1 mediated diseases such as atopic—and allergic dermatitis in young animals.

Claims20

Dependent claims

A method of treating a JAK-1 mediated disease of a companion animal comprising administering to the companion animal an effective dose of a compound of Formula (I) or a pharmaceutically acceptable salt or stereoisomer thereof

wherein the companion animal is selected from dog, cat, and horse and is younger than 12 months of age.

Dependencies are inferred from the claim text.

Facts

Application

18/721,916Filed 23 Dec 2022

Priority

EP 21217736.424 Dec 2021

Published

13 Feb 2025

Term ends

Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
C07D 405/14
Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having…:…
A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61P 17/00
Drugs for dermatological disorders

Abstract

Claims20

Dependent claims

wherein the companion animal is selected from dog, cat, and horse and is younger than 12 months of age.

Dependencies are inferred from the claim text.

Use of aminopyrazole compounds

Life of this patent

Abstract

Claims20

Use of aminopyrazole compounds

Life of this patent

Abstract

Claims20